Otitis externa affects an estimated ten percent of people during their lifetimes, driven by environmental and anatomical factors like swimming, humidity, and ear canal stenosis. While most cases stem from bacterial infections, understanding the anatomy and underlying risks shapes how clinicians approach diagnosis and evidence-based treatment.
Anatomy and Physiology of the Ear Canal
The external auditory canal spans two to three and a half centimeters in length with a diameter measuring five to nine millimeters. Its structure features lateral cartilaginous sections and medial bony portions. The skin in the bony ear canal binds tightly to the underlying periosteum. In contrast, the skin of the cartilaginous ear canal rests on a layer of connective tissue packed with hair follicles, sebaceous glands, and apocrine ceruminous glands. The exudates from these glands combine with desquamated epithelial cells to form cerumen.
This earwax plays a critical role in ear health. The canal maintains a natural pH range of 5 to 5.7, and this acidic environment alongside the hydrophobic properties of cerumen works to inhibit bacterial growth. Sensory innervation reaches the ear canal through the auriculotemporal nerve, the auricular branch of the vagus nerve, the greater auricular nerve, and the posterior auricular nerve. However, anatomical vulnerabilities exist. The floor of the cartilaginous ear canal contains the connective-tissue clefts of Santorini, which provide pathways along which infections can spread toward the parotid gland, infratemporal fossa, and skull base.
Etiology, Epidemiology, and Predisposing Factors
Otitis externa occurs globally, with higher infection rates found in tropical regions due to elevated temperatures and humidity. Annual incidence sits around one percent, though swimming multiplies that risk by fivefold, earning the condition its common moniker, swimmer’s ear. The condition primarily targets adults, appearing only rarely in children typically aged seven to twelve.
More than ninety percent of acute cases originate from bacterial pathogens. Pseudomonas aeruginosa and Staphylococcus aureus dominate these infections, though polymicrobial involvement occurs frequently. Fungal causes are less common in acute presentations but appear more often in chronic cases, with Aspergillus and Candida species representing typical culprits.
Connecting Outer and Middle Ear Pathology
While external ear infections remain localized to the outer canal, inflammation can progress or mirror conditions deeper within the auditory system. Otitis media involves inflammation or infection of the middle ear cavity and frequently follows otitis externa or Eustachian tube dysfunction. Paediatric populations experience middle ear disease most heavily, whereas companion animals often see chronic outer ear disease advance directly into middle ear complications.
Diagnostic evaluation for deeper or complex ear disease relies on direct otoscopic examination, video-otoscopy, and advanced imaging modalities such as computed tomography or magnetic resonance imaging to evaluate the middle ear and tympanic bulla. First-line management typically incorporates systemic or topical antimicrobials driven by cytology and culture results, anti-inflammatory measures, and targeted treatment of underlying triggers like allergies.
Surgical Interventions and Advanced Management
When conservative medical therapies fail to resolve chronic or severe ear pathology, surgical intervention becomes necessary. Procedures range from myringotomy and tympanostomy tube placement to more extensive operations required for persistent infection or structural masses. Advanced surgical procedures include lateral bulla osteotomy and total ear canal ablation combined with lateral bulla osteotomy, a comprehensive approach aimed at eradicating severe disease when the canal structure is irreversibly compromised.
Clinical presentation across advanced ear disease spans from head-shaking, otorrhoea, and localized discomfort to severe vestibular signs and central nervous system involvement. Ongoing medical research continues to explore the middle ear microbiome, host immune dynamics, and novel drug delivery systems to refine personalized, less invasive treatment strategies for persistent ear disease across human and veterinary medicine.